Biocryst Archives - Page 2 of 5 - Biocryst

Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Hereditary Angioedema Patients Would Prefer Newer-Generation Oral Prophylaxis

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Managing Diagnosis, Treatment and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Optimal Management of Hereditary Angioedema: Shared Decision-Making

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Meeting Patient Needs in Hereditary Angioedema Care

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Once-daily oral berotralstat for long-term prophylaxis of hereditary angioedema: The open-label extension of the APeX-2 randomized trial

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)